MARC Record from marc_columbia

LEADER: 05736cam a2200457 a 4500
001 1443607
005 20220602035541.0
008 930811s1994 nyua b 001 0 eng c
010 $a 93030258
020 $a0195073347 (alk. paper)
035 $a(OCoLC)28721330
035 $a(OCoLC)ocm28721330
035 $9AHW3045CU
035 $a(NNC)1443607
035 $a1443607
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aR723.5$b.P48 1994
060 00 $aW1 MO567LT v. 23 1994$aWA 950 P491m 1994
082 00 $a614.4/072$220
100 1 $aPetitti, Diana B.$0http://id.loc.gov/authorities/names/n93803494
245 10 $aMeta-analysis, decision analysis, and cost-effectiveness analysis :$bmethods for quantitative synthesis in medicine /$cDiana B. Petitti.
260 $aNew York :$bOxford University Press,$c1994.
300 $ax, 246 pages :$billustrations ;$c25 cm.
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
490 1 $aMonographs in epidemiology and biostatistics ;$v23
504 $aIncludes bibliographical references (p. 229-237) and index.
505 0 $a1. Introduction. 1.1. Three Illustrative Problems. 1.2. Definitions. 1.3. Historical Perspective. 1.4. Linkages of the Three Methods. 1.5. Organization of the Book -- 2. Overview of the Methods. 2.1. Meta-Analysis. 2.2. Decision Analysis. 2.3. Cost-Effectiveness Analysis -- 3. Planning the Study. 3.1. Defining the Problem. 3.2. Developing a Study Protocol. 3.3. Acquiring Resources. 3.4. Procuring Administrative Approvals -- 4. Information Retrieval. 4.1. Overall Strategy for Retrieving Information on Published Studies. 4.2. Computerized Searches of MEDLINE. 4.3. Other Computer-Stored Databases. 4.4. Limitations of Computerized Searches of Computer-Stored Databases. 4.5. Publication Bias -- 5. Data Collection. 5.1. Overall Goals. 5.2. Reliability. 5.3. Validity. 5.4. Bias -- 6. Advanced Issues in Meta-Analysis. 6.1. Defining Eligibility Criteria and Determining Eligibility of Individual Studies. 6.2. Study Design. 6.3. Inclusive Dates of Publication. 6.4. English-Language Publications.
505 0 $a6.5. Multiple Publications from the Same Study Population. 6.6. Restrictions on Sample Size or Length of Follow-Up. 6.7. Eligibility Based on Similarity of Treatments (or Exposures) or Outcomes. 6.8. Completeness of Information. 6.9. Choosing Estimates of Effect Within Eligible Studies. 6.10. Incorporating Information on Study Quality -- 7. Statistical Methods in Meta-Analysis. 7.1. Model Choice. 7.2. Choice of Effect Measure. 7.3. Mantel-Haenszel Method. 7.4. Peto Method. 7.5. General Variance-Based Methods. 7.6. General Variance-Based Methods That Use Confidence Intervals. 7.7. Statistical Tests of Homogeneity. 7.8. DerSimonian and Laird Method -- 8. Other Statistical Issues in Meta-Analysis. 8.1. Measures on a Continuous Scale. 8.2. Estimating Trend. 8.3. Modeling in Meta-Analysis. 8.4. Vote Counting and Related Methods. 8.5. Statistical Approaches to Publication Bias -- 9. Complex Decision Problems. 9.1. More Than One Outcome. 9.2. More Than Two Alternative Treatments or Interventions.
505 0 $a9.3. Many Intervening Events. 9.4. Estimating Life Expectancy. 9.5. Markov Models -- 10. Estimating Probabilities. 10.1. Overall Goals. 10.2. Relying on Selected Published Sources of Information on Probabilities. 10.3. Aggregating Information from Multiple Published Sources. 10.4. Expert Panels as Sources of Probability Estimates. 10.5. Personal Experience and "Guessing" to Estimate Probabilities. 10.6. Accounting for Uncertainty in Probability Estimates -- 11. Utility Analysis. 11.1. The Concept of Utility. 11.2. Conceptual Issues in the Measurement of Preferences for Health States. 11.3. Developing Measurement Scales in Practice. 11.4. Incorporating Measures of Preference for Health States into Decision Analysis. 11.5. Limitations of Measures of Preferences for Health States -- 12. Advanced Cost-Effectiveness Analysis. 12.1. Key Concepts. 12.2. Costs. 12.3. Estimating Costs. 12.4. Discounting Costs. 12.5. Inflation. 12.6. Discounting Benefits. 12.7. Time Horizon -- 13. Sensitivity Analysis.
505 0 $a13.1. Goals of Sensitivity Analysis. 13.2. One-Way Sensitivity Analysis in Decision Analysis and Cost-Effectiveness Analysis. 13.3. Two-Way, Three-Way, and n-Way Sensitivity Analysis. 13.4. Application of the Principles of Sensitivity Analysis to Meta-Analysis -- 14. Reporting Results. 14.1. Meta-Analysis. 14.2. Decision Analysis. 14.3. Cost-Effectiveness Analysis. 14.4. Graphical Presentation of the Results of Meta-Analysis. 14.5. Graphical Presentation of the Results of Decision Analysis and Cost-Effectiveness Analysis -- 15. Limitations. 15.1. Meta-Analysis. 15.2. Decision Analysis. 15.3. Cost-Effectiveness Analysis. 15.4. Problems with Life Expectancy as an Outcome Measure. 15.5. Values and Ethics and the Quality-Adjusted Life Year. 15.6. Situations Where the Methods Are Most and Least Useful.
650 0 $aMedicine$xDecision making.$0http://id.loc.gov/authorities/subjects/sh2008107655
650 0 $aStatistical decision.$0http://id.loc.gov/authorities/subjects/sh85127565
650 0 $aMeta-analysis.$0http://id.loc.gov/authorities/subjects/sh85084006
650 0 $aCost effectiveness.$0http://id.loc.gov/authorities/subjects/sh85033197
650 2 $aMeta-Analysis as Topic.$0https://id.nlm.nih.gov/mesh/D015201
650 2 $aDecision Support Techniques.$0https://id.nlm.nih.gov/mesh/D003661
650 2 $aCost-Benefit Analysis.$0https://id.nlm.nih.gov/mesh/D003362
830 0 $aMonographs in epidemiology and biostatistics ;$vv. 23.$0http://id.loc.gov/authorities/names/n42017012
852 00 $bmat$hR723.5$i.P48 1994